Status:
COMPLETED
Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome
Lead Sponsor:
Novartis
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
Other effects of fluvastatin are investigated in German patients with metabolic syndrome.
Eligibility Criteria
Inclusion
- Written informed consent
- Male and female patients, aged between 18 and 75 years
- Metabolic syndrome according to National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII)
Exclusion
- History of heart failure
- HIV positive
- Stroke
- Other protocol defined inclusion and exclusion criteria may apply.
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2006
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT00138528
Start Date
October 1 2004
End Date
February 1 2006
Last Update
February 23 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novartis
Nuremberg, Germany